Viewing Study NCT02055157


Ignite Creation Date: 2025-12-24 @ 6:57 PM
Ignite Modification Date: 2026-01-04 @ 1:42 PM
Study NCT ID: NCT02055157
Status: COMPLETED
Last Update Posted: 2021-01-15
First Post: 2013-04-18
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Phase 2 Study of BMN 111 to Evaluate Safety, Tolerability, and Efficacy in Children With Achondroplasia
Sponsor: BioMarin Pharmaceutical
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2014-01-13
Start Date Type: ACTUAL
Primary Completion Date: 2017-10-02
Primary Completion Date Type: ACTUAL
Completion Date: 2017-10-02
Completion Date Type: ACTUAL
First Submit Date: 2013-04-18
First Submit QC Date: None
Study First Post Date: 2014-02-05
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2020-09-18
Results First Submit QC Date: None
Results First Post Date: 2021-01-15
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: 2018-09-24
Disp First Post Date Type: ACTUAL
Last Update Submit Date: 2020-12-22
Last Update Post Date: 2021-01-15
Last Update Post Date Type: ACTUAL